Towards an optimal therapy strategy for myogenous TMD, physiotherapy compared with occlusal splint therapy in an RCT with therapy-and-patient-specific treatment durations

Table 2 Success rate, treatment duration and number of visits

	Phyiotherapy	Splint therapy	P-value and significance of difference
Number of patients	37	35
SR (% patients) at EM	73%	83%	0.339 NS^†
SR (% patients) at LM	51%	60%	0.487 NS^†
Duration of treatment [mean, weeks (SD)]	13.8 (6.5)	24.2 (9.2)	p < 0.0001^‡
Number of visits [mean, (SD)]	11.5 (2.0)	4.4 (1.1)	p < 0.0001^‡

SR, success rate. EM, end-measurement of treatment outcome in the short-term, at the first post-treatment visit. LM, last measurement of treatment outcome in the long-term, at the last post-treatment visit. LM only includes an entire follow-up of 1 year for patients whose treatment continues to be successful from EM. number of visits: from the first visit of treatment (thus excluding the initial visit with intake) to the visit with the last control by the clinician included. ^† squared-Chi test. ^‡ Student’s t-test for unpaired observations

ISSN: 1471-2474